Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$1.63 - $2.83 $73,837 - $128,196
-45,299 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$2.45 - $3.45 $128,117 - $180,410
-52,293 Reduced 53.58%
45,299 $120,000
Q2 2021

Aug 16, 2021

SELL
$3.3 - $5.02 $54,888 - $83,497
-16,633 Reduced 14.56%
97,592 $334,000
Q1 2021

May 17, 2021

BUY
$4.29 - $9.94 $156,507 - $362,631
36,482 Added 46.93%
114,225 $576,000
Q4 2020

Feb 16, 2021

BUY
$2.41 - $5.63 $161,359 - $376,951
66,954 Added 620.58%
77,743 $365,000
Q3 2020

Nov 16, 2020

BUY
$0.97 - $4.08 $10,465 - $44,019
10,789 New
10,789 $43,000

Others Institutions Holding EVGN

# of Institutions
1
Shares Held
117K
Call Options Held
0
Put Options Held
0

About Evogene Ltd.


  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $66.7M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.